| _version_ | 1866901720519409664 |
|---|---|
| author | Mamoor, Shahan |
| author_facet | Mamoor, Shahan |
| contents | <p>We measured total transcription by RNA-sequencing in patients sensitive or resistant to treatment with trastuzumab for HER2+ breast cancer for discovery of genes that confer or support resistance to HER2-targeted therapies in humans. In this manuscript we describe identification of Meox2 as a candidate gene product of the trastuzumab resistance gene expression signature. </p> <p> </p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20225164 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | An expression screen to identify genes important for trastuzumab resistance: Meox2. Mamoor, Shahan <p>We measured total transcription by RNA-sequencing in patients sensitive or resistant to treatment with trastuzumab for HER2+ breast cancer for discovery of genes that confer or support resistance to HER2-targeted therapies in humans. In this manuscript we describe identification of Meox2 as a candidate gene product of the trastuzumab resistance gene expression signature. </p> <p> </p> |
| title | An expression screen to identify genes important for trastuzumab resistance: Meox2. |
| url | https://doi.org/10.5281/zenodo.20225164 |